18F-Misonidazole

N/A

Report date: 2023/01/01 08:31:55

Base Information

Drug Name18F-Misonidazole

Drug Alias Name1-(2-Nitro-imidazolyl)-3-[18F]fluoro-2-propanol; 1H-1-(3-[18F]fluoro-2-hydroxypropyl0-2-nitroimidazole (18F-Misonidazole)FMISO-[18F]Fluoro-18-FMISO[18F] FMISO PET agent (rhabdomyosarcoma/DIPG), Advanced Imaging ProjectsAIP-105 +[6]

ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agent

Mechanisms of ActionUndefined mechanism

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAdvanced Imaging Projects

China Registration ClassN/A

Develop Information

Active CompaniesAdvanced Imaging Projects

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A